Mark John E. Eribal, APRN
Nurse Practitioners (Family Nurse Practitioner)
At a glance
- Years since graduation
- 2
- In the NPI registry since
- 2020
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2020Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
NY license 346242
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in New York, NY | 95 |
| Pomalyst (pomalidomide) | 68 |
| Eliquis (apixaban) Other prescribers in New York, NY | 54 |
| Hydroxyurea Other prescribers in New York, NY | 35 |
| Jakafi (ruxolitinib phosphate) | 35 |
| Lenalidomide | 33 |
| Revlimid (lenalidomide) | 33 |
| Xarelto (rivaroxaban) Other prescribers in New York, NY | 29 |
| Letrozole Other prescribers in New York, NY | 23 |
| Ibrance (palbociclib) | 20 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 34 payments worth $896 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $483 |
|---|---|
| AbbVie Inc. | $124 |
| Janssen Biotech, Inc. | $95.26 |
| Pharmaessentia USA Corporation | $55.91 |
| Daiichi Sankyo Inc. | $55.86 |
| Apellis Pharmaceuticals, Inc. | $39.95 |
| Astellas Pharma US Inc | $23.66 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.43 |
| Food and Beverage | $896 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.